IPA - Transcultural Psychogeriatrics: An International Symposium Presented in Munich at Aging 2000
Meeting Report
Transcultural Psychogeriatrics: An International Symposium
Presented in Munich at Aging 2000
Meinhardt S. Tropper, MD, PhD
A symposium dedicated to transcultural psychogeriatrics was presented
during IPA's recent Joint Meeting in Munich. The first part of the
introductory lecture, Transcultural Psychogeriatrics, paid tribute to Emil
Kraepelin, the father of psychiatric nosology, and emphasized that comparative
ethnopsychology (volkerpsychologie) and comparative psychiatry were founded by
this outstanding psychiatrist, scientist, and educator, who worked so
creatively in Munich in the first decades of our century. The lecture
emphasized current demographic changes in the world - the increased life span
and huge migration waves (from Eastern to Western Europe, Southeast Asia to
Australia and North America, Africa towards Europe, etc.); the aging of the
"gastarbeiters" in Germany; and the wars in Rwanda, Zaire, Yugoslavia and
elsewhere, which bring refugees in their wake. Based on data from a
longitudinal comparative study (1974-1997) of 1,614 elderly immigrants from
countries of the Former Soviet Union, who are now in Israel, I reported on
differences due to cultural diversity in the manifestation of
psychopathological symptoms and syndromes in dementia, as well as in
depression, anxiety, compliance, service utilization, reactivation of
stressful events in the past, and psychosomatic disorders.
As a result of global events, an increased number of psychopathological
phenomena in the elderly, considered to be influenced by ethnical-cultural
characteristics, have drawn the attention of health professionals as well as
ministries and departments of immigration and acculturation in the USA,
Canada, Australia, Germany, UK, New Zealand, France, Israel, and other
countries. Many elderly communities in large cities become multi-cultural and
multi-ethnic. This represents an issue of concern for authorities and medical
institutions, as well as a topic of psychogeriatric research.
This field could and should be named transcultural psychogeriatrics.
Culture is defined as a social cohort set of meanings, customs, and beliefs,
reflected in people's actions, behavior, language, interaction, and shared
experiences. Cultural psychiatry is a field concerned with the etiology,
symptomatology, diagnosis, treatment, prevention, and prognosis of mental
disorders, within a particular culture. As a result transcultural
psychogeriatrics represents an expansion of cultural psychiatry towards older
age groups, and includes the pertinent symptoms, signs, syndromes and related
psychosocial issues, which extend beyond the boundaries of one culture.
Some of the main topics for study in this field would include: the cultural
context of behavioral and psychological symptoms of dementia (BPSD),
depressive disorders, anxiety, pain syndromes, somatization, communicative
aspects of older people's complaints, the relationship between elderly
language capacity in the hosting country, and mental health services
utilization, transcultural patterns of drug use in the elderly, identical
ethnicity and cultural diversity of the elderly in countries of mass
immigration, and psychotherapy performed in the elderly patient's native
language.
H. Bickel (Germany) presented a lecture on the protective and adverse
effects of drug use on cognitive decline in a prospective study of elderly
general practice patients in Germany. The essence of the study, which was
carried out by him and his colleagues, was to explore associations of use by
German elderly of psychotropics and drugs which are claimed to protect against
cognitive decline and dementia. The study was based on a stratified random
sample drawn from a total of 3,700 patients who attended their GPs during a
four-week period. After a mean interval of 27 months, repeated assessments of
the whole sample were carried out. The presented findings refer to patients
who initially showed no, or only minimal or mild, cognitive impairment,
according to the CAMDEX criteria. The conclusions drawn from this naturalistic
longitudinal study are: cognition enhancing drugs may have preventive effects
on cognitive decline among elderly people, and antidepressive drugs may have
the potential to cause additional cognitive impairment.
S. Hazama (Japan) reported on the survival rate of patients with dementia,
based on data gathered during 1987-1992 in Okinawa. The study results support
previous publications indicating a more favorable prognosis in the Japanese
population with Alzheimer's disease, than those with Vascular Dementia (VaD),
and also determined a longer life expectancy of women in Okinawa who have the
most favorable record in Japan. G.H. Suh (Korea) presented a survey on
prevalence and risk factors for AD and VaD in 1,037 elderly in a Korean rural
community. Statistically significant factors for AD (age over 85, illiteracy,
alcohol use, and family history of dementia) were listed. Statistically
significant risk factors for VaD included illiteracy and family history. The
survey's results suggest that AD is more prevalent than VaD in Korea.
A. Henry (France), in a lecture on the psychiatric hospital and the old,
described the peculiarities and specificity of geropsychiatric services in
France, in particular the psychotherapeutic and ethical aspects of the work
with the elderly, and the necessity to take into consideration their cultural
background.
About the Author
Meinhardt S. Tropper, MD, PhD, directs the Department of Geriatric
Psychiatry of the United Meuhedet Health Fund, Bar Ilan University, Tel Aviv,
Israel (tel: +972 3 739 4198, fax +972 3 696 1804). He is a former member of
IPA's Board of Directors and served with distinction as Chair of IPA's Fifth
Congress, held in Rome in 1991.
Reprinted from IPA Bulletin, Volume 16, Number 1
Copyright 2008 International Psychogeriatric Association